| Bioactivity | Anti-Heart Failure Agent 1 an orally available compound suitable for the treatment of heart failure without inducing nausea, vomiting and restlessness. |
| In Vivo | 15 mg/kg of compound produces 60% increase in left ventricular contractility in anaesthetized cat. An oral dose of compound (25 mg/kg) could produce marked increases in left ventricular contractility (45%) in conscious dog[1]. |
| Name | Anti-Heart Failure Agent 1 |
| CAS | 142648-47-3 |
| Formula | C11H11FN2O3S |
| Molar Mass | 270.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. EP0482717A1 |
Anti-Heart Failure Agent 1
CAS: 142648-47-3 F: C11H11FN2O3S W: 270.28
Anti-Heart Failure Agent 1 an orally available compound suitable for the treatment of heart failure without inducing nau
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.